文献速递神经外科与老年麻醉术前评估与围术期医学

氯胺酮与高危脑:术后谵妄与认知障碍的再审视

Ketamine and the At-Risk Brain.
PubMed 文献 · Anesth Analg · 2022-09-15

本文围绕Chang等的研究,探讨术前存在认知障碍的老年脊柱手术患者对术中氯胺酮的脑电反应及术后谵妄发生情况。所有接受氯胺酮者脑电功率谱密度均增加,但术前认知障碍者反应显著减弱且术后谵妄发生率更高。社论据此讨论氯胺酮作为认知风险分层工具的可能性及避免使用的考量。

要点

  • 术前认知障碍患者对氯胺酮的脑电反应减弱,术后谵妄发生率更高。
  • 氯胺酮可能用于认知风险分层,但需结合情境局限解读研究结果。
  • 建议阅读原文及社论以全面理解氯胺酮与认知结局的关系。

核心结论

  • 术前存在认知障碍的老年脊柱手术患者对术中氯胺酮的脑电反应显著减弱,且术后谵妄发生率增加。

研究设计与样本

  • 研究纳入65岁及以上、脊柱手术时长超过3小时的患者,按术前有无认知障碍分组,各组内再分为接受或不接受术中氯胺酮。

主要发现

  • 所有接受术中氯胺酮的患者脑电图功率谱密度均增加。
  • 术前已存在认知障碍的患者对氯胺酮的脑电反应显著减弱。
  • 该亚组术后谵妄发生率更高。

临床怎么用

  • 对术前认知障碍的老年脊柱手术患者,应警惕氯胺酮相关术后谵妄风险增加。
  • 氯胺酮的脑电反应或可用于认知风险分层,但需结合研究情境局限谨慎解读。

局限性

  • 解读本研究结果时需考虑多种情境局限性,详见原文及社论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postoperative cognitive dysfunction and delirium are undesirable consequences of surgery and anesthesia that regrettably do not have consistent predictive markers. Nor do they have reliable prophylactic or treatment methodologies. In an effort to better understand how anesthetic drugs alter the rate of postoperative delirium, Chang et al explore how patients with preoperative cognitive impairment respond to the influence of intraoperative ketamine. Patients aged 65 or older presenting for spine surgery lasting over three hours were assessed and divided into those with and without baseline cognitive impairment. Both groups either received intraoperative ketamine or did not. All patients who received intraoperative ketamine demonstrated an increase in power spectral density via electroencephalographic assessment. However, patients with preoperatively established cognitive impairment displayed a significantly diminished electroencephalographic response to ketamine. Furthermore, this subgroup also suffered an increased incidence of postoperative delirium. What is the interpretation of this finding? An accompanying editorial elegantly describes how disorders of cognition result from both predisposing and precipitating factors. In this case, patients with known cognitive impairment were more likely to endure delirium when exposed to ketamine. Is it possible that ketamine and other drugs could be used as agents to stratify cognitive risk? Should we definitively avoid such drugs as potentiators of cognitive dysfunction? A variety of contextual limitations must be entertained when interpreting the results of this study as summarized in this infographic. These are also elaborated in greater detail in both the primary article as well as its attendant editorial. The reader is encouraged to review both in their entirety for an in-depth scope of understanding.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Nathan N. Ketamine and the At-Risk Brain. Anesth Analg. 2022. PMID: 36108179. doi:10.1213/ANE.0000000000006212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。